145 related articles for article (PubMed ID: 32381923)
1. [pCR Achievement in Two Cases Treated with XELOXIRI as Neoadjuvant Chemotherapy for Locally Advanced Rectal Cancer].
Ozato Y; Tei M; Sueda T; Matsumura T; Furukawa H; Koga C; Wakasugi M; Miyagaki H; Kawabata R; Shimizu J; Miwa H; Hasegawa J
Gan To Kagaku Ryoho; 2020 Mar; 47(3):484-486. PubMed ID: 32381923
[TBL] [Abstract][Full Text] [Related]
2. [A Case of Pathological CR in Local Advanced Rectal Cancer Treated with Laparoscopic ISR after XELOXIRI Chemotherapy].
Kawai K; Murata K; Hata T; Kagawa Y; Naito A; Sakamoto T; Murakami K; Katsura Y; Omura Y; Masuzawa T; Takeno A; Takeda Y
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2096-2097. PubMed ID: 32157071
[TBL] [Abstract][Full Text] [Related]
3. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
[TBL] [Abstract][Full Text] [Related]
4. [A Case of Laparoscopic Surgery for Advanced Rectal Cancer with Lateral Lymph Node Metastasis Resected after Neoadjuvant Chemotherapy].
Motoki Y; Sugimoto K; Sakisaka H; Nakano K; Kan K; Nakaguchi K; Doi S
Gan To Kagaku Ryoho; 2018 Dec; 45(13):2357-2359. PubMed ID: 30692463
[TBL] [Abstract][Full Text] [Related]
5. [Two Cases of Locally Advanced Lower Rectal Cancer with Pathological Complete Response after Cetuximab plus SOX as Neoadjuvant Chemotherapy].
Tokuhara K; Satake R; Ueyama Y; Yamamichi K; Sekimoto M
Gan To Kagaku Ryoho; 2021 Nov; 48(11):1405-1407. PubMed ID: 34795136
[TBL] [Abstract][Full Text] [Related]
6. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
[No Abstract] [Full Text] [Related]
7. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
8. [The safety and efficacy of radical surgery after modified total neoadjuvant therapy for locally advanced rectal cancer].
Zhang L; Yu L; Wu YL; Zhang QQ; Shen SH; Li DD; Fang H; Yang L; Zhang HZ
Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):501-506. PubMed ID: 32575948
[No Abstract] [Full Text] [Related]
9. Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.
Eisterer W; Piringer G; DE Vries A; Öfner D; Greil R; Tschmelitsch J; Samonigg H; Sölkner L; Gnant M; Thaler J;
Anticancer Res; 2017 May; 37(5):2683-2691. PubMed ID: 28476845
[TBL] [Abstract][Full Text] [Related]
10. [A Case of Pathological Complete Response after Neoadjuvant Chemotherapy(S-1 plus Oxaliplatin)and Laparoscopic Low Anterior Resection for Rectal Cancer].
Ichinohe D; Morohashi H; Umetsu S; Yoshida T; Wakasa Y; Odagiri T; Kimura T; Suto A; Saito T; Yoshida E; Akasaka H; Jin H; Miura T; Sakamoto Y; Hakamada K
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1715-1717. PubMed ID: 28133108
[TBL] [Abstract][Full Text] [Related]
11. [Two Cases of Unresectable Advanced Rectal Cancer with a Long-Term Survival for Which Pathological Complete Response Was Achieved through Neoadjuvant Effective Chemotherapy].
Gonda K; Tachiya Y; Hatakeyama Y; Shibata M; Kono K; Rokkaku Y
Gan To Kagaku Ryoho; 2017 Oct; 44(10):944-946. PubMed ID: 29066704
[TBL] [Abstract][Full Text] [Related]
12. [A case of pathological complete response with neoadjuvant XELOX chemotherapy for locally advanced rectal cancer].
Kitahara T; Takemasa I; Inoue A; Osawa H; Miyo M; Mokutani Y; Ogawa H; Naito A; Hamabe A; Hiraki M; Munakata K; Uemura M; Nishimura J; Hata T; Mizushima T; Yamamoto H; Doki Y; Mori M
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1569-71. PubMed ID: 25731255
[TBL] [Abstract][Full Text] [Related]
13. [Two Cases of Pathological Complete Response with Neoadjuvant Therapy for Advanced Rectal Cancer].
Matsuda C; Danno K; Miyazaki S; Fujitani K; Kubota M; Motoori M; Nakatsuka R; Okumura Y; Nomura M; Nishimura M; Kitagawa A; Matsuura N; Fushimi H; Iwase K
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2313-5. PubMed ID: 26805348
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of neoadjuvant chemoradiotherapy followed by total mesorectal excision surgery for locally advanced rectal cancer: a single-institution experience.
Tseng MSF; Zheng H; Ng IWS; Leong YH; Leong CN; Yong WP; Cheong WK; Tey JCS
Singapore Med J; 2018 Jun; 59(6):305-310. PubMed ID: 29167909
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II study.
Yu X; Wang QX; Xiao WW; Chang H; Zeng ZF; Lu ZH; Wu XJ; Chen G; Pan ZZ; Wan DS; Ding PR; Gao YH
Cancer Commun (Lond); 2018 May; 38(1):24. PubMed ID: 29784042
[TBL] [Abstract][Full Text] [Related]
16. A Phase I Study of Neoadjuvant Capecitabine, Oxaliplatin, and Irinotecan (XELOXIRI) in Patients with Locally Advanced Rectal Cancer.
Kudo T; Takemasa I; Hata T; Sakai D; Takahashi H; Haraguchi N; Nishimura J; Hata T; Matsuda C; Satoh T; Mizushima T; Mori M; Doki Y
Oncology; 2019; 97(4):211-216. PubMed ID: 31266024
[TBL] [Abstract][Full Text] [Related]
17. [A Case of Locally Advanced Rectal Cancer with Invasion to Other Organs in Which Pathological Complete Response Was Obtained with Neoadjuvant Chemotherapy].
Kanesada K; Suzuki N; Yoshida S; Tomochika S; Matsui H; Matsukuma S; Shindo Y; Tokumitsu Y; Iida M; Takeda S; Yoshino S; Hazama S; Shirahama T; Kawano H; Nagano H
Gan To Kagaku Ryoho; 2020 Mar; 47(3):531-533. PubMed ID: 32381939
[TBL] [Abstract][Full Text] [Related]
18. [A Case of Pathological Complete Response with Neoadjuvant Chemotherapy for Advanced Rectal Cancer].
Okada S; Kameyama H; Abe K; Tanaka K; Oyanagi H; Nakano M; Ichikawa H; Hanyu T; Takizawa K; Nakano M; Nagahashi M; Shimada Y; Sakata J; Kobayashi T; Wakai T
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2057-2059. PubMed ID: 32157058
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
[No Abstract] [Full Text] [Related]
20. Preliminary results of a cohort study of induction chemotherapy-based treatment for locally recurrent rectal cancer.
van Zoggel DMGI; Bosman SJ; Kusters M; Nieuwenhuijzen GAP; Cnossen JS; Creemers GJ; van Lijnschoten G; Rutten HJT
Br J Surg; 2018 Mar; 105(4):447-452. PubMed ID: 29168556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
